WNT5A and non-small cell lung carcinoma: In addition, it has been described that by inhibiting miR-347a, it could target Wnt5a (protein Wnt-5a) and reduce tumors in gefitinib-resistant NSCLC cells in xenograft (gefitinib-resistant HCC827 cell line transplanted into xenograft).